Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Dionysopoulou, Anna; Pirih, Etienne; Macchiella, Doris et al.
The Cardiovascular Profile Score in Patients with Non-immune Hydrops Fetalis and Cardiac Anomalies - a Pilot StudyREPRODUCTIVE SCIENCES. Bd. 30. H. 9. 2023 S. 2805-2812
Friedrich, Maria Laura; Loeffler, Marius; Shehaj, Inna et al.
THE CLINICAL RELEVANCE OF FRACTIONAL CURETTAGE IN pT2 STAGE PRIMARY ENDOMETRIAL CANCERANTICANCER RESEARCH. Bd. 43. H. 7. 2023 S. 3378-3378
Kiweler, Nicole; Helena, Schwarz; Nguyen, Alexandra et al.
The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracilCELL BIOLOGY AND TOXICOLOGY. Bd. 39. H. 5. 2023 S. 2401-2419
Battista, Marco Johannes; Anic, Katharina; Linz, Valerie et al.
The impact of different global health assessment tools on the prognosis of older ovarian cancer patients-results of a retrospective single institution cohort studyZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE. Bd. 56. 2023 S. S3-S4
Loeffler, Marius; Friedrich, Maria; Shehaj, Inna et al.
THE PROGNOSTIC RELEVANCE OF THE LYMPH NODE RATIO IN PRIMARY ENDOMETRIAL CANCERANTICANCER RESEARCH. Bd. 43. H. 7. 2023 S. 3370-3370
Klar, Maximilian; Plett, Helmut; Harter, Philipp et al.
Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft fu''r Gynakologische Onkologie (AGO) study group CORSETT databaseJOURNAL OF SURGICAL ONCOLOGY. Bd. 128. H. 1. 2023 S. 111-118
Decker, T.; Brucker, C.; Engel, A. et al.
Treatment of elderly patients (pts; > 75 years) with 1st line ribociclib (RIB) plus aromatase inhibitor (AI)/fulvestrant (FUL) or endocrine monotherapy (ET) in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))ONCOLOGY RESEARCH AND TREATMENT. Bd. 46. 2023 S. 168-169
Decker, T.; Brucker, C.; Fasching, P. et al.
Treatment of elderly patients (pts; > 75 years) with 1st-line ribociclib (RIB) plus endocrine therapy (ET) or endocrine monotherapy in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))ANNALS OF ONCOLOGY. Bd. 34. 2023 S. S354-S355
Roser, Eva; Harter, Philipp; Zocholl, Dario et al.
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023
Battista, Marco Johannes; Anic, Katharina; Linz, Valerie et al.
Two-step frailty assessment algorithm for women with various gynecological malignancies-results of an interim-analysis of a prospective observational cohort studyZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE. Bd. 56. 2023 S. S3-S3